Dr. Drew W Rasco, MD
Claim this profileSTART South Texas Accelerated Research Therapeutics
Expert in Cancer
Studies Solid Tumors
22 reported clinical trials
35 drugs studied
About Drew W Rasco, MD
Education:
- Earned an MD from the University of Texas Health Sciences Center, San Antonio, TX, in 2003.
Experience:
- Completed residency in Internal Medicine at Emory University School of Medicine, Atlanta, GA.
- Fellowships in Hematology and Oncology at the University of Texas Southwestern Medical Center, Dallas, TX.
- Board-certified in Hematology and Oncology.
- Associate Director of Clinical Research at South Texas Accelerated Research Therapeutics (START).
- Principal investigator for research leading to FDA approval of treatments, including the combination of lenvatinib and pembrolizumab for endometrial cancer in 2019.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
ARID1A positive
2Solid Tumors
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Drew W Rasco, MD is currently running
FX-909
for Bladder Cancer
This trial tests a new tablet called FX-909 for safety and proper dosage in patients with advanced solid tumors, especially advanced urothelial carcinoma. Doctors will closely monitor patients to understand how the drug works and its effects on the body and tumors.
Recruiting1 award Phase 1
GSK4381562
for Cancer
This trial tests a new drug called GSK4381562 in patients with recurring or spreading tumors who have no other treatment options. It will see how the drug is processed by the body, its safety, and any immune responses it might cause.
Recruiting2 awards Phase 13 criteria
More about Drew W Rasco, MD
Clinical Trial Related9 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Drew W Rasco, MD has experience with
- Pembrolizumab
- Dostarlimab
- Aldesleukin
- AU-007
- CC-95251
- Cetuximab
Breakdown of trials Drew W Rasco, MD has run
Cancer
Solid Tumors
Pancreatic Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Drew W Rasco, MD specialize in?
Drew W Rasco, MD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Drew W Rasco, MD currently recruiting for clinical trials?
Yes, Drew W Rasco, MD is currently recruiting for 9 clinical trials in Grand Rapids Michigan. If you're interested in participating, you should apply.
Are there any treatments that Drew W Rasco, MD has studied deeply?
Yes, Drew W Rasco, MD has studied treatments such as Pembrolizumab, Dostarlimab, Aldesleukin.
What is the best way to schedule an appointment with Drew W Rasco, MD?
Apply for one of the trials that Drew W Rasco, MD is conducting.
What is the office address of Drew W Rasco, MD?
The office of Drew W Rasco, MD is located at: START South Texas Accelerated Research Therapeutics, Grand Rapids, Michigan 49503-2563 United States. This is the address for their practice at the START South Texas Accelerated Research Therapeutics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.